The insulin-like growth factor system and markers of inflammation in adult patients with inflammatory bowel disease

Hormone Research

Volumn 64, Issue 1, 2005, Pages 9-15

  Eivindson, M ^a,b   Nielsen, J N ^a   Gronbaek H ^b   Flyvbjerg, A ^b   Hey, H ^b  

^a LILLEBAELT HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Crohn's disease; IGF I; IGF II; IGFBP 3; Inflammatory bowel disease; Interleukin 6; Ulcerative colitis

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; INTERLEUKIN 6; OROSOMUCOID; SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN C;

ADULT; ARTICLE; CATABOLISM; CORRELATION ANALYSIS; CROHN DISEASE; DISEASE ACTIVITY; DISEASE MARKER; ENTERITIS; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MUSCLE METABOLISM; PRIORITY JOURNAL; RELAPSE; REMISSION; SCORING SYSTEM; ULCERATIVE COLITIS;

ADULT; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; COLITIS, ULCERATIVE; CROHN DISEASE; CROSS-SECTIONAL STUDIES; ENDOPEPTIDASES; FEMALE; HEMOGLOBINS; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; INTERLEUKIN-6; LEUKOCYTE COUNT; MALE; MIDDLE AGED; OROSOMUCOID; SERUM ALBUMIN;

EID: 23944499072     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000087190     Document Type: Article

References (36)

1. Tenore A, Berman WF, Parks JS, Bongiovanni AM: Basal and stimulated serum growth hormone concentrations in inflammatory bowel disease. J Clin Endocrinol Metab 1977;44:622-628.
2. Chong SK, Bartram C, Campbell CA, Williams CB, Blackshaw AJ, Walker-Smith JA: Chronic inflammatory bowel disease in childhood. Br Med J (Clin Res Ed) 1982;284:101-103.
3. Ballinger AB, Camacho-Hübner C, Croft NM: Growth failure and intestinal inflammation. QJM 2001;94:121-125.
4. Juul A: Serum levels of insulin-like growth factor I and its binding proteins in health and disease. Growth Horm IGF Res 2003;13:113-170.
5. Bannerjee K, Camacho-Hübner C, Babinska K, Dryhurst KM, Edwards R, Savage MO, Sanderson IR: Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease. J Pediatr Gastroenterol Nutr 2004;38:270-275.
6. Bach LA, Rechler MM: Insulin-like growth factor binding proteins. Diabetes Rev 1995;3:38-61.
7. Davenport ML, Isley WL, Pucilowska JB, Pemberton LB, Lyman B, Underwood LE, Clemmons DR: Insulin-like growth factor-binding protein-3 proteolysis is induced after elective surgery. J Clin Endocrinol Metab 1992;75:590-595.
8. De Groof F, Joosten KF, Janssen JA, de Kleijn ED, Hazelzet JA, Hop WC, Uitterlinden P: Acute stress response in children with meningococcal sepsis: important differences in the growth hormone/insulin-like growth factor I axis between nonsurvivors and survivors. J Clin Endocrinol Metab 2002;87:3118-3124.
9. Timmins AC, Cotterill AM, Hughes SC, Holly JM, Ross RJ, Blum W, Hinds CJ: Critical illness is associated with low circulating concentrations of insulin-like growth factors-I and -II, alterations in insulin-like growth factor binding proteins, and induction of an insulin-like growth factor binding protein 3 protease. Crit Care Med 1996;24:1460-1466.
10. Grønbæk H, Thøgersen T, Frystyk J, Vilstrup H, Flyvbjerg A, Dahlerup JF: Low free and total insulin-like growth factor I (IGF-I) and IGF binding protein-3 levels in chronic inflammatory bowel disease: partial normalization during prednisolone treatment. Am J Gastroenterol 2002;97:673-678.
11. Beagley KW, Elson CO: Cells and cytokines in mucosal immunity and inflammation. Gastroenterol Clin North Am 1992;21:347-366.
12. Gross V, Andus T, Leser HG, Roth M, Scholmerich J: Inflammatory mediators in chronic inflammatory bowel diseases. Klin Wochenschr 1991;69:981-987.
13. Mitsuyama K, Sata M, Tanikawa K: Significance of interleukin-6 in patients with inflammatory bowel disease. Gastroenterol Jpn 1991;26:20-28.
14. Brown KA, Back SJ, Ruchelli ED, Markowitz J, Mascarenhas M, Verma R, Piccoli DA: Lamina propria and circulating interleukin-6 in newly diagnosed pediatric inflammatory bowel disease patients. Am J Gastroenterol 2002;97:2603-2608.
15. Hosokawa T, Kusugami K, Ina K, Ando T, Shinoda M, Imada A, Ohsuga M: Interleukin-6 and soluble interleukin-6 receptor in the colonic mucosa of inflammatory bowel disease. J Gastroenterol Hepatol 1999;14:987-996.
16. Indaram AV, Visvalingam V, Locke M, Bank S: Mucosal cytokine production in radiation-induced proctosigmoiditis compared with inflammatory bowel disease. Am J Gastroenterol 2000;95:1221-1225.
17. De Benedetti F, Meazza C, Oliveri M, Pignatti P, Vivarelli M, Alonzi T, Fattori E: Effect of IL-6 on IGF binding protein-3: a study in IL-6 transgenic mice and in patients with systemic juvenile idiopathic arthritis. Endocrinology 2001;142:4818-4826.
18. De Benedetti F, Alonzi T, Moretta A, Lazzaro D, Costa P, Poli V, Martini A: Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. J Clin Invest 1997;99:643-650.
19. Thissen JP Verniers J: Inhibition by interleukin-1β and tumor necrosis factor-α of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture. Endocrinology 1997;138:1078-1084.
20. Ballinger A, Azooz O, Bajaj-Elliot M, Farthing MJ: The reduction in insulin-like growth factor-1 and linear growth in a rat model of colitis is mediated by the combined inhibitory effects of interleukin-6 and undernutrition. Gastroenterology 2001;120(suppl):A-210
21. Street ME, de'Angelis G, Camacho-Hübner C, Giovannelli G, Ziveri MA, Bacchini PL, Bernasconi S: Relationships between serum IGF-1, IGFBP-2, interleukin-1β and interleukin-6 in inflammatory bowel disease. Horm Res 2004;61:159-164.
22. Larsen TB, Nielsen JN, Fredholm L, Lund ED, Brandslund I, Munkholm P, Hey H: Platelets and anticoagulant capacity in patients with inflammatory bowel disease. Pathophysiol Haemost Thromb 2002;32:92-96.
23. Best WR, Becktel JM, Singleton JW, Kern F Jr: Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology 1976;70:439-444.
24. Seo M, Okada M, Yao T, Ueki M, Arima S, Okumura M: An index of disease activity in patients with ulcerative colitis. Am J Gastroenterol 1992;87:971-976.
25. Frystyk J, Dinesen B, Ørskov H: Non-competitive time-resolved immunofluorometric assays for determination of human insulin-like growth factor I and II. Growth Regul 1995;5:169-176.
26. Lamson G, Giudice LC, Rosenfeld RG: A simple assay for proteolysis of IGFBP-3. J Clin Endocrinol Metab 1991;72:1391-1393.
27. Murch SH, Lamkin VA, Savage MO, Walker-Smith JA, MacDonald TT: Serum concentrations of tumour necrosis factor-α in childhood chronic inflammatory bowel disease. Gut 1991;32:913-917.
28. Mahida YR, Kurlac L, Gallagher A, Hawkey CJ: High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis. Gut 1991;32:1531-1534.
29. Katsanos KH, Tsatsoulis A, Christodoulou D, Challa A, Katsaraki A, Tsianos EV: Reduced serum insulin-like growth factor-1 (IGF-1) and IGF-binding protein-3 levels in adults with inflammatory bowel disease. Growth Horm IGF Res 2001;11:364-367.
30. Brain CE, Savage MO: Growth and puberty in chronic inflammatory bowel disease. Baillières Clin Gastroenterol 1994;8:83-100.
31. O'Dell SD, Day IN: Insulin-like growth factor II. Int Biochem Cell Biol 1998;30:767-771.
32. Cabré E, Gassull MA: Nutritional and metabolic issues in inflammatory bowel disease. Curr Opin Clin Nutr Metab Care 2003;6:569-576.
33. Ghosh S, Cowen S, Hannan WJ, Ferguson A: Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis. Gastroenterology 1994;107:1031-1039.
34. Jahnsen J, Falch JA, Aadland E, Mowinckel P: Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. Gut 1997;40:313-319.
35. Vestergaard P, Mosekilde L: Fracture risk in patients with celiac Disease, Crohn's disease, and ulcerative colitis: a nationwide follow-up study of 16,416 patients in Denmark. Am J Epidemiol 2002;156:1-10.
36. Heszele MF Price SR: Insulin-like growth factor I: the yin and yang of muscle atrophy. Endocrinology 2004;145:4803-4805.